Medicine & Life Sciences
Child
31%
Control Groups
38%
Diabetic Ketoacidosis
26%
Glucose
6%
Hyperglycemia
9%
Hypoglycemia
9%
Insulin
35%
Intention
9%
N-(4-((1-acetoamidoyl-4-piperidyl)oxy)phenyl)-N-((7-amidino-2-naphtyl)methyl)sulfamoyl acetic acid
26%
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
16%
Pediatrics
6%
Population
4%
Random Allocation
40%
Randomized Controlled Trials
48%
Safety
12%
Smartphone
12%
Software
7%
Therapeutics
5%
Type 1 Diabetes Mellitus
64%
Business & Economics
Adverse Events
12%
Clinical Trials
5%
Diabetes
89%
Efficacy
13%
Funding
4%
Glucose
7%
Inclusion
3%
Insulin
36%
Kidney
6%
Median
4%
Multinationals
4%
Pediatrics
5%
Prototype
4%
Randomization
23%
Randomized Controlled Trial
100%
Registration
5%
Safety
8%
Screening
4%
Sensor
11%
Smartphone
5%
Software
3%
Telephone
9%
Therapy
11%
United States of America
1%